Biofeedback for Dysfunctional Voiding and Giggle Incontinence

November 25, 2025 updated by: Furkan Adem Canbaz, Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Biofeedback for Dysfunctional Voiding and Giggle Incontinence in Children

This study aims to evaluate the efficacy of biofeedback treatment for dysfunctional voiding and giggle incontinence in children. Predictive factors of treatment success will also researched.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

A total of approximately 60 patients who received biofeedback therapy will be evaluated retrospectively. Treatment success rates among these patients will be evaluated. Patients will be divided into mainly two groups according to the diagnosis.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Kadikoy
      • Istanbul, Kadikoy, Turkey (Türkiye), 34000
        • Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who were received biofeedback therapy for dysfunctional voiding and giggle incontinece in pediatric urology clinic of Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital

Description

Inclusion Criteria:

  • Patients diagnosed with dysfunctional voiding or giggle incontinence
  • Patients treated with biofeedback therapy

Exclusion Criteria:

  • Presence of anatomical or neurological problems
  • Patients with missing data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Giggle incontinence
Patients who received biofeedback therapy for giggle incontinence
Behavioral: Biofeedback therapy
Biofeedback therapy is a behavioral treatment method that helps patients become more aware of and gain better control over their pelvic floor muscles. Using EMG electrodes, muscle activity is monitored and presented to the patient visually or audibly, enabling them to recognize and correct improper muscle contractions or relaxations that contribute to urinary incontinence.
Dysfunctional voiding
Patients who received biofeedback therapy for dysfunctional voiding
Behavioral: Biofeedback therapy
Biofeedback therapy is a behavioral treatment method that helps patients become more aware of and gain better control over their pelvic floor muscles. Using EMG electrodes, muscle activity is monitored and presented to the patient visually or audibly, enabling them to recognize and correct improper muscle contractions or relaxations that contribute to urinary incontinence.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with Biofeedback-Related Resolution
Time Frame: From enrollment to the end of treatment at 18 weeks
Participants achieved a complete response which means 100% improvement in resolution of incontinence and abnormal voiding pattern
From enrollment to the end of treatment at 18 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Predictive Factors of Treatment Response
Time Frame: 18 weeks
Age, gender, and diagnosis will be evaluated as potential predictive factors of treatment response
18 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

November 25, 2025

First Submitted That Met QC Criteria

November 25, 2025

First Posted (Actual)

December 8, 2025

Study Record Updates

Last Update Posted (Actual)

December 8, 2025

Last Update Submitted That Met QC Criteria

November 25, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BF DV + Giggle

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

I do not have any idea.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dysfunctional Voiding

Clinical Trials on Biofeedback therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe